Browse the evidence

Activation of AMP-Activated Protein Kinase (AMPK) inhibits white adipose tissue (WAT) development and promotes the differentiation of brown/beige adipose tissue, thereby increasing energy expenditure and reducing obesity.

While you cannot directly 'take' AMPK, the paper identifies it as the central regulator of energy balance. Strategies that activate AMPK (such as exercise, caloric restriction, or specific pharmacological targets mentioned like BMP-8b) can shift the body's fat storage from energy-storing white fat to energy-burning brown/beige fat. This suggests that interventions focusing on metabolic rate and fat quality are more effective than those focusing solely on fat quantity.

Doubling dietary leucine intake via drinking water supplementation improves glucose tolerance, insulin signaling, and reduces hepatic steatosis and adipose inflammation in high-fat diet-induced obese mice without altering total body weight or food intake.

In a mouse model of obesity, doubling dietary leucine (via water supplementation) improved how the body handles glucose and reduced liver fat and inflammation, without causing weight loss. This suggests that ensuring adequate leucine intake might support metabolic health in obese individuals, although human translation requires caution as this was an animal study.

Skeletal muscle aging independently increases the risk of insulin resistance through a convergence of mitochondrial dysfunction, intramyocellular lipid accumulation, chronic inflammation, oxidative stress, and sarcopenia.

As you age, your muscles naturally become less efficient at processing glucose due to cellular stress and inflammation. To counter this, prioritize resistance training and aerobic exercise, which directly improve mitochondrial function and reduce inflammation, thereby preserving your insulin sensitivity despite aging.

Mitochondrial dysfunction in aging skeletal muscle, characterized by reduced oxidative capacity and increased ROS production, directly impairs insulin signaling and promotes insulin resistance.

Supporting mitochondrial health through regular physical activity is crucial for maintaining metabolic flexibility and insulin sensitivity as you age.

Intramyocellular lipid (IMCL) accumulation, specifically the buildup of ceramides and diacylglycerol (DAG), impairs insulin signaling by activating inflammatory pathways and interfering with Akt activity.

Managing body fat and lipid metabolism through diet and exercise helps prevent the accumulation of harmful lipids like ceramides in muscles, protecting insulin sensitivity.

Chronic low-grade inflammation (inflammaging) in skeletal muscle, driven by factors like TNF-α and IL-1β, activates IKKβ/NF-κB and JNK pathways, which phosphorylate IRS-1 on serine residues, thereby blocking normal insulin signaling.

Reducing systemic inflammation through anti-inflammatory dietary patterns and exercise can help maintain healthy insulin signaling in muscles.

The association between underweight status (BMI <20) and fecundability is conditional on parity: it is associated with reduced fecundability in nulliparous women but increased fecundability in parous women.

If you are underweight (BMI <20), your fertility status depends on your history. If you have never had children, being underweight may make it harder to conceive. However, if you have had children before, being underweight might actually be associated with a higher chance of conceiving in each cycle.

Dietary intake of oleic acid (specifically via high-oleic peanut oil) reverses the inhibitory effect of the inflammatory cytokine TNF-α on insulin production and reduces blood glucose levels in type II diabetic models.

Incorporating foods high in oleic acid, such as specific high-oleic peanut oils or olive oil, may help mitigate the negative metabolic effects of chronic inflammation. For individuals with Type II Diabetes, this specific fatty acid profile appears to support insulin production where standard high-fat diets might not, potentially aiding in glucose regulation.

Incorrect timing or high doses of melatonin administered late relative to endogenous melatonin onset can result in no phase advance or even a delay in the circadian rhythm.

Taking melatonin too late in the evening or in high doses can worsen DSPD by delaying your sleep phase. Timing is more critical than dose.

Dietary restriction and exercise delay aging by enhancing Sirtuin activity, which deacetylates histones and substrates to protect against age-related diseases and extend healthspan.

Adopting dietary restriction (without malnutrition) and regular exercise can boost Sirtuin activity. This metabolic shift helps maintain healthy gene expression patterns, potentially delaying the onset of age-related diseases like cancer and neurodegeneration. Focus on consistent lifestyle habits rather than quick fixes.

The anti-seizure effects of ketogenic diets in animal models of epilepsy and autism are mediated by specific gut bacteria (Akkermansia and Parabacteroides) that modulate the GABA/glutamate ratio in the brain.

This mechanism is primarily relevant for understanding the biological basis of KD in neurological disorders. It suggests that the gut microbiome is a key target for therapeutic intervention in epilepsy and autism, potentially allowing for microbiome-based therapies alongside or instead of strict dietary changes.

Obstructive Sleep Apnea (OSA) is independently associated with insulin resistance and type II diabetes, but CPAP therapy does not consistently reverse these metabolic dysregulations.

If you have OSA, treating it is important for metabolic health, but CPAP alone may not reverse insulin resistance, especially if you are obese or do not use it consistently. Prioritize good sleep hygiene and weight management alongside medical treatment for OSA.

Thyroid hormone receptor beta (THRβ) agonists and specific thyroid hormone metabolites (T2, T1AM) reduce hepatic lipid content and serum cholesterol in NAFLD and hypercholesterolemia models by stimulating fatty acid oxidation and cholesterol clearance without the cardiac side effects of natural thyroid hormones.

Current standard care for NAFLD focuses on lifestyle changes. However, emerging research indicates that specific thyroid hormone analogs and metabolites (like T2 and T1AM) are being developed to treat liver fat and high cholesterol. These are not yet available as standard treatments but represent a promising future direction for patients who do not respond to lifestyle interventions. Do not self-administer thyroid hormones; consult a specialist about clinical trials if eligible.

Thyroid-stimulating hormone (TSH) directly promotes hepatic lipogenesis and cholesterol biosynthesis, worsening NAFLD and hypercholesterolemia, independent of its role in stimulating thyroid hormone production.

If you have high TSH levels, even if your T3/T4 are normal, it may contribute to fatty liver and high cholesterol. Treating hypothyroidism to normalize TSH might help improve these metabolic markers, although lifestyle changes remain the primary treatment for NAFLD.

Glucagon-Thyroid Hormone (T3) conjugates reduce liver fat and improve dyslipidemia in obesity models by targeting the liver specifically, avoiding the cardiac and skeletal side effects of systemic T3 therapy.

Research is exploring new ways to deliver thyroid hormones to the liver to treat fatty liver disease without affecting the heart or bones. One promising approach involves linking T3 to glucagon to target the liver. This is still experimental and not available as a standard treatment.

High baseline levels of the hepatokine Selenoprotein P (SeP) are associated with 'exercise resistance,' blunting the beneficial metabolic adaptations to exercise and reducing aerobic capacity in obese individuals.

If you are obese and struggling to lose weight despite exercise, high levels of Selenoprotein P might be blunting your results. The paper suggests you may need longer duration or higher intensity exercise to overcome this 'exercise resistance' and improve your body's ability to use fat for fuel.

Beige adipocytes can repress adipose tissue fibrosis and improve glucose homeostasis through mechanisms independent of UCP1 and body weight reduction.

Activating beige fat may improve metabolic health by preventing fat tissue scarring (fibrosis), which helps glucose regulation even without significant weight loss.

Acute resistance exercise directly modulates circadian clock gene expression (Cry1, Per2, Bmal1) in human skeletal muscle, suggesting peripheral muscle clocks can respond independently of the central suprachiasmatic nucleus.

Performing resistance exercise can directly reset the internal biological clocks within your muscles. This happens at the gene level (specifically Cry1, Per2, and Bmal1) within 6 hours of a workout. This suggests that exercise is a potent tool for aligning your body's peripheral rhythms, potentially aiding sleep and metabolic health, even without changes to your central sleep-wake cycle.

Ketone bodies, specifically beta-hydroxybutyrate (BHB), have complex, potentially contradictory effects on appetite regulation by influencing AMPK phosphorylation and GABA levels, which may counteract hunger suppression.

Be aware that ketones might trigger some hunger signals via AMPK and GABA, but in practice, the hormonal suppression of ghrelin usually wins out, leading to net hunger reduction.

Loss-of-function mutations in the zinc transporter SLC30A8 (ZnT8) reduce the risk of type 2 diabetes in humans, likely by preventing the formation of toxic human islet amyloid polypeptide (hIAPP) oligomers through altered insulin oligomerization dynamics.

Do not assume zinc supplementation is a cure-all for diabetes. While deficiency is a risk factor, the paper suggests that genetic variations in zinc transport (ZnT8) significantly impact diabetes risk, and excessive zinc intake may actually worsen metabolic markers. Focus on overall nutrient balance rather than high-dose supplementation without medical guidance.

Losartan treatment restores skeletal muscle remodeling and reduces fibrosis in sarcopenic mice following injury by modulating canonical and noncanonical TGF-β signaling pathways.

This preclinical study suggests that Losartan, a common blood pressure medication, may help older adults recover better from muscle injuries by reducing scarring (fibrosis). While not a direct fitness intervention, it highlights a potential pharmacological strategy for managing sarcopenia-related muscle damage. Consult a physician before considering medication repurposing.

Losartan protects against disuse atrophy in sarcopenic mice during hindlimb immobilization by upregulating the IGF-1/Akt/mTOR pathway, independent of TGF-β signaling.

For older adults facing periods of immobility (e.g., recovery from surgery), this study suggests Losartan might help preserve muscle mass by boosting protein synthesis pathways. This is a preclinical finding; human application requires clinical validation. Discuss potential benefits with a doctor, especially regarding blood pressure management.

Chronic activation of AMPK using the direct activator A-769662 promotes white adipose tissue browning, increases energy expenditure, and protects against diet-induced obesity and metabolic dysfunction in high-fat diet-fed mice.

This study suggests that directly activating the AMPK enzyme in fat cells using a specific compound (A-769662) can help burn fat and prevent obesity in mice. While this is not a human supplement, it supports the idea that boosting cellular energy sensors (like AMPK) through exercise or diet might mimic these effects.

Genetic deficiency of STAT6 leads to increased fatty acid oxidation and resistance to diet-induced obesity, but results in insulin resistance and glucose intolerance due to hepatic steatosis.

This finding highlights a trade-off in metabolic regulation: blocking the STAT6 pathway prevents fat gain but harms insulin sensitivity. It illustrates that 'lean' does not always mean 'metabolically healthy,' as ectopic fat storage in the liver can still cause insulin resistance.